Evidence map›Paper›PMID 30409036›Full record

ArticleCell transplantation2019

Early and Late Protective Effect of Bone Marrow Mononuclear Cell Transplantation on Radiation-Induced Vascular Dysfunction and Skin Lesions.

Valérie Holler, Valerie Buard, Telma Roque, Claire Squiban, Marc Benderitter, Stephane Flamant, Radia Tamarat

Open access · goldAbstract read
In one paragraph

Article in Cell transplantation, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.7field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Valérie Holler1 Institute for Radiological Protection and Nuclear Safety (IRSN), PSE-SANTE, Fontenay aux Roses, France.
Valerie Buard1 Institute for Radiological Protection and Nuclear Safety (IRSN), PSE-SANTE, Fontenay aux Roses, France.
Telma Roque1 Institute for Radiological Protection and Nuclear Safety (IRSN), PSE-SANTE, Fontenay aux Roses, France.
Claire Squiban1 Institute for Radiological Protection and Nuclear Safety (IRSN), PSE-SANTE, Fontenay aux Roses, France.
Marc Benderitter1 Institute for Radiological Protection and Nuclear Safety (IRSN), PSE-SANTE, Fontenay aux Roses, France.
Stephane Flamant1 Institute for Radiological Protection and Nuclear Safety (IRSN), PSE-SANTE, Fontenay aux Roses, France.
Radia Tamarat1 Institute for Radiological Protection and Nuclear Safety (IRSN), PSE-SANTE, Fontenay aux Roses, France.
Institut de Radioprotection et de Sûreté Nucléaire · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Skin lesions caused by accidental exposure to radiation or by radiotherapy are a major clinical challenge. We evaluated the effect of bone marrow mononuclear cells (BMMNC) on collagen remodeling and vascular function in radiation-induced skin lesions in the acute and late phases in mice. We studied the effect of BMMNC transplantation in a mouse model of cutaneous radiation injury combining local skin gamma-irradiation and biopsy punch wound. Mice were first irradiated, punched and then BMMNC were intramuscularly administered. Seven days after injury, BMMNC promoted wound healing by (i) increasing re-epithelialization, tissue collagen density and mRNA levels of collagens 1A1, 1A2, and 3A1, and (ii) inhibiting the radiation-induced vascular activation and limiting interactions between leukocytes and the vascular endothelium compared with control. Importantly, BMMNC did not amplify the inflammatory response despite the infiltration of neutrophils and macrophages associated with the expression of IL-6 and MCP-1 mRNAs in the tissue. Remarkably, the beneficial effects of BMMNC therapy on matrix remodeling were maintained for 2 months. Furthermore, BMMNC injection restored vascular function in skin tissue by increasing vascular density and vascular permeability. This therapeutic strategy based on BMMNC injection protects against radiation-induced skin lesions by preventing vascular dysfunction and unfavorable remodeling in the acute and late phases.

Indexed as

AnimalsBone Marrow TransplantationChemokine CCL2CollagenDisease Models, AnimalImmunohistochemistryInterleukin-6MaleMiceMice, Inbred C57BLSkinWound HealingChemokine CCL2CollagenInterleukin-6BMMNCcollagenirradiationskinwound healing

Identifiers

PMID30409036
PMCPMC6322140
OpenAlexW2899530452

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.